V
Venancio Avancini Ferreira Alves
Researcher at University of São Paulo
Publications - 140
Citations - 6009
Venancio Avancini Ferreira Alves is an academic researcher from University of São Paulo. The author has contributed to research in topics: Internal medicine & Cancer. The author has an hindex of 29, co-authored 122 publications receiving 5192 citations. Previous affiliations of Venancio Avancini Ferreira Alves include French Institute of Health and Medical Research & Sao Paulo State University.
Papers
More filters
Journal ArticleDOI
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors
Yuri E. Nikiforov,Raja R. Seethala,Giovanni Tallini,Zubair W. Baloch,Fulvio Basolo,Lester D.R. Thompson,Justine A. Barletta,Bruce M. Wenig,Abir Al Ghuzlan,Kennichi Kakudo,Thomas J. Giordano,Venancio Avancini Ferreira Alves,Elham Khanafshar,Sylvia L. Asa,Adel K. El-Naggar,William E. Gooding,Steven P. Hodak,Ricardo V. Lloyd,Guy Maytal,Ozgur Mete,Marina N. Nikiforova,Vania Nosé,Mauro Papotti,David N. Poller,Peter M. Sadow,Arthur S. Tischler,R. Michael Tuttle,Kathryn B. Wall,Virginia A. LiVolsi,Gregory W. Randolph,Ronald Ghossein +30 more
TL;DR: Thyroid tumors currently diagnosed as noninvasive EFVPTC have a very low risk of adverse outcome and should be termed NIFTP, and this reclassification will affect a large population of patients worldwide and result in a significant reduction in psychological and clinical consequences associated with the diagnosis of cancer.
Journal ArticleDOI
Pathologic Diagnosis of Early Hepatocellular Carcinoma: A Report of the International Consensus Group for Hepatocellular Neoplasia
Masamichi Kojiro,Ian R. Wanless,Venancio Avancini Ferreira Alves,Sunil Badve,Charles Balabaud,Pierre Bedosa,Prithi S. Bhathal,P. Bioulac-Sage,Elizabeth M. Brunt,Alastair D. Burt,John R. Craig,Amar P. Dhillon,Linda D. Ferrell,Stephen A. Geller,Zackary D. Goodman,Annette S.H. Gouw,Maria Guido,Maha Guindi,Prodromos Hytiroglou,Masayoshi Kage,Fukuo Kondo,Masutoshi Kudo,Gregory Y. Lauwers,Masayuki Nakano,Valérie Paradis,Young Nyun Park,Alberto Quaglia,Massimo Roncalli,Tania Roskams,Boris Ruebner,Michiie Sakamoto,Romil Saxena,Neil D. Theise,Swan Thung,Dina Taniakos +34 more
TL;DR: The International Consensus Group for Hepatocellular Neoplasia (ICGHN) was convened in April 2002 in Kurume, Japan and met several times up to July 2007 and this consensus document summarizes the results of the authors' meetings.
Journal ArticleDOI
Lung Pathology in Fatal Novel Human Influenza A (H1N1) Infection
Thais Mauad,Ludhmila Abrahão Hajjar,Giovanna D. Callegari,Luiz Fernando Ferraz da Silva,Denise Schout,Filomena Regina Barbosa Gomes Galas,Venancio Avancini Ferreira Alves,Denise Maria Avancini Costa Malheiros,José Otávio Costa Auler,Aurea F. Ferreira,Marcela R. L. Borsato,Stephania M. Bezerra,Paulo Sampaio Gutierrez,Elia Garcia Caldini,Carlos Augusto Pasqualucci,Marisa Dolhnikoff,Paulo Hilário Nascimento Saldiva +16 more
TL;DR: Autopsies have shown that the main pathological changes associated with S-OIV infection are localized to the lungs, where three distinct histological patterns can be identified.
Journal ArticleDOI
Adrenocortical carcinoma: clinical and laboratory observations.
Bernardo Leo Wajchenberg,Albergaria Pereira Ma,Medonca Bb,Ana Claudia Latronico,Campos Carneiro P,Venancio Avancini Ferreira Alves,Maria Claudia Nogueira Zerbini,Bernardo Liberman,Carlos Gomes G,Marvin A. Kirschner +9 more
TL;DR: The clinical features and natural history of adrenocortical carcinoma are highly dependent on the type of center reporting their experience, whereas reports from endocrine clinics emphasize excessive corticoid and androgen production in the majority of tumors.
Journal ArticleDOI
Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
Céline Pinheiro,Adhemar Longatto-Filho,Adhemar Longatto-Filho,Cristovam Scapulatempo,Luisa A. Ferreira,Sandra F. Martins,Luc Pellerin,Mesquita Rodrigues,Venancio Avancini Ferreira Alves,Fernando Schmitt,Fátima Baltazar +10 more
TL;DR: The increased expression of Monocarboxylate transporters suggests an important role in CRC, which might justify their use, especially MCT1 and MCT4, as targets in CRC drug therapy.